about
Effects of antenatal glucocorticoid therapy on hippocampal histology of preterm infants.Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.Long-term functional consequences and ongoing cerebral inflammation after subarachnoid hemorrhage in the rat.Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse.Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes.The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies.Intronic polyadenylation of PDGFRα in resident stem cells attenuates muscle fibrosis.The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment.Stem cells for neonatal stroke- the future is here.Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.The neonatal brain is not protected by osteopontin peptide treatment after hypoxia-ischemia.Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damageRepeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor funcMesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration.Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain.Transcriptional Profiling of Quiescent Muscle Stem Cells In Vivo.Staufen1 inhibits MyoD translation to actively maintain muscle stem cell quiescence.Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage.Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice.Targeting the p53 pathway to protect the neonatal ischemic brain.Alternative polyadenylation of Pax3 controls muscle stem cell fate and muscle function
P50
Q34211845-211E38AD-A176-455F-82C6-F59DEB64A31CQ34385062-7FD46F2C-2832-463C-A6AE-C78548F18E93Q34903919-FC64C396-851C-42C7-93E0-D80429CEE008Q35112800-B9E54B1D-7B48-44F9-8E02-C0FEDCDB79D1Q36254898-F7AA4443-4B05-4D20-9905-2EF01EFFEB72Q37434845-C8A1714B-E109-47B0-8D05-18D51A22F180Q37479890-C0E71111-BB44-456D-97E8-5C76A848FDAFQ37741521-AF7D48A1-916E-40B0-ADEE-F28E0F401FEEQ38081017-FBAD5FDD-CC3D-4863-9363-BD40E6F0BF38Q39145353-B6B57E7E-DA59-42CD-9B41-4229127507C5Q39249577-605C7139-7D44-443C-AE6B-55ACB9EDC189Q41234761-F12A2746-E3AC-4089-8A5C-FA5CE1CE7715Q41876349-22F7D9E8-CE93-41AC-AEF3-E71216DF6730Q42970221-08D3CBB5-C5F7-480F-B166-2B6F0571A58CQ43250238-ED80D852-EBA5-4582-858A-282A4D3CB266Q44525786-67BA9A01-A1BF-45B4-9211-81A5DB18098AQ47145179-6E450EB5-A968-4B5A-84DA-482DD96FFB8FQ47600535-A220120B-5D81-4451-B458-342A6E0F7B7CQ48122882-566BF2A7-3AC5-4615-A0F5-98BE1FFF6566Q48465778-716FD5FF-F504-403E-8517-A47D48374E77Q51864096-37A688B7-FA95-41D6-A3EB-CEC149D26FB7Q91173185-EC8E6BDD-66A9-4307-A4CF-D05130B510FD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cindy van Velthoven
@ast
Cindy van Velthoven
@en
Cindy van Velthoven
@es
Cindy van Velthoven
@nl
type
label
Cindy van Velthoven
@ast
Cindy van Velthoven
@en
Cindy van Velthoven
@es
Cindy van Velthoven
@nl
prefLabel
Cindy van Velthoven
@ast
Cindy van Velthoven
@en
Cindy van Velthoven
@es
Cindy van Velthoven
@nl
P106
P21
P31
P496
0000-0001-5120-4546